Abbott rolls out SimpleScreen colorectal cancer blood test developed by Freenome
Abbott (NYSE:ABT) has begun rolling out a blood test to help screen for colorectal cancer […]
Abbott (NYSE:ABT) has begun rolling out a blood test to help screen for colorectal cancer […]
Merck & Co. has become the latest pharma to jump on the KRAS G12D bandwagon, […]
DEER PARK, Ill., Sept. 28, 2026 /PRNewswire/ — Leica Biosystems, a Danaher company (the “Company”) […]
SEOUL, South Korea, Sept. 28, 2026 /PRNewswire/ — Lunit (KRX:328130), a leading provider of AI […]
SAN JOSE, Calif., Sept. 21, 2026 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: […]
Neptune Medical has landed an FDA clearance for its robotic system designed to provide stable […]
MADISON, Wis., Sept. 11, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems […]
DermaSensor today announced four new partnerships to accelerate growth of its skin-cancer-detecting device. Earlier this year, […]
SUNNYVALE, Calif., Aug. 20, 2026 /PRNewswire/ — MaxQ Medical, Inc., a private health-tech company developing an all-in-one transurethral […]
MENLO PARK, Calif., Aug. 20, 2026 /PRNewswire/ — Maverix Medical, a company focused on revolutionizing the diagnosis […]
Data from Monteris Medical’s new post-market study published in the Journal of Clinical Oncology demonstrates that extent of […]
Johnson & Johnson MedTech (NYSE: JNJ) today announced the launch of Monarch Quest 3, the […]
Noah Medical has launched its Galaxy II software, the next evolution of the company’s robotic-assisted bronchoscopy […]
OXFORD, England and SEOUL, South Korea, Aug. 13, 2026 /PRNewswire/ — Optellum and Coreline Soft today announced their intent to collaborate […]
LONG ISLAND CITY, N.Y., Aug. 11, 2026 /PRNewswire/ — Ceramedix, Inc., a privately held New York City-based […]
NEW YORK, Aug. 5, 2026 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical […]
LAKE SUCCESS, N.Y., Aug. 5, 2026 /PRNewswire/ — Samir S. Taneja, MD, a urologic oncologist, chairman of […]
NASHVILLE, Tenn., Aug. 3, 2026 /PRNewswire/ — Tennessee Oncology, which treats nearly half the cancer patients in […]
GE HealthCare (Nasdaq:GEHC) announced today that it launched its new Invenia ABUS Prime and ABUS StreamVue […]
LONDON, July 22, 2026 /PRNewswire/ — GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration […]
DEER PARK, Ill., July 14, 2026 /PRNewswire/ — Leica Biosystems, an operating company of Danaher (the “Company”), […]
NEW YORK, July 14, 2026 /PRNewswire/ — Nucs AI, a company developing AI-powered diagnostic and predictive imaging […]
Egg Medical announced today that it launched its EggNest Complete 2.0 advanced enhanced radiation protection device […]
BURLINGTON, N.C. and ST. LOUIS, June 22, 2026 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive […]
GHENT, Belgium, June 18, 2026 /PRNewswire/ — XEOS, a medical technology company advancing intraoperative molecular imaging, today […]
AngioDynamics (Nasdaq:ANGO) announced today that it received FDA investigational device exemption (IDE) to initiate the RELIEF […]
DermaSensor announced today that it received Class IIb CE mark approval for its skin cancer detection […]
TEMPE, Ariz., June 9, 2026 /PRNewswire/ — GT Medical Technologies, Inc., a medical device company dedicated to […]
CLARK, N.J., June 8, 2026 /PRNewswire/ — Metropolitan Dermatology is proud to announce the addition of Nevisense®, a […]
QUICKBORN, Germany, June 4, 2026 /PRNewswire/ — Mammotome, a Danaher company and global leader in breast care […]
Philips (NYSE:PHG) today unveiled SmartIQ, its coronary imaging technology for the Azurion image-guided therapy platform. Amsterdam-based Philips developed […]
DALLAS, May 14, 2026 /PRNewswire/ — Cancer Check Labs, creator of CancerCheck, a one-of-a-kind multi-cancer early detection […]
SAN ANTONIO, May 14, 2026 /PRNewswire/ — Valion Bio, Inc. (formerly Tivic Health Systems, Inc.) (Nasdaq: VBIO), a […]
PALO ALTO, Calif., May 13, 2026 /PRNewswire/ — DELFI Diagnostics, Inc., developer of innovative blood-based tests that leverage cell-free […]
AVONDALE, Pa., May 5, 2026 /PRNewswire/ — CQ Medical, the global leader in patient radiotherapy positioning and […]
PALO ALTO, Calif., May 1, 2026 /PRNewswire/ — Sonire Therapeutics, a U.S.-based clinical-stage medical device company, today announced […]
NEW YORK, April 22, 2026 /PRNewswire/ — Utepreva LLC today announced the launch of the Utepreva Endometrial Sampler, a […]
NEW YORK, April 23, 2026 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical […]
EDMONTON, AB, April 20, 2026 /PRNewswire/ – Nanostics Inc., a precision health company advancing diagnostic innovation through its […]